3-Fluoroiodobenzene | CAS:1121-86-4
3-Fluoroiodobenzene
- 名称:3-氟碘苯; 间氟碘苯; 1-氟-3-碘苯 | 3-Fluoroiodobenzene
- CAS号:1121-86-4
- 别名:1-Fluoro-3-iodobenzene
- 分子式:C6H4FI
- 分子量:222.00
- EINESC号:214-339-9
产品描述
物理化学性质
沸点 | 77-78 ºC (19 mmHg) |
---|---|
闪点 | 67 ºC |
密度 | 1.89 |
折射率 | 1.583-1.585 |
安全数据
危险品标志 | Xi |
---|---|
危险类别码 | R36/37/38 |
安全说明书 | S26;S37/39 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
In silico insight into voltage-gated sodium channel 1.7 inhibition for anti-pain drug discovery.Mingxing Wang et al.Journal of molecular graphics & modelling, 84, 18-28 (2018-05-25)
Synthesis, Biological Evaluation and QSAR Studies of Newer Isoxazole Derivatives.Sahaya Asirvatham et al.Anti-inflammatory & anti-allergy agents in medicinal chemistry, 14(2), 128-137 (2015-08-13)
Time-Resolved Photoelectron Spectroscopy Studies of Isoxazole and Oxazole.Ting Geng et al.The journal of physical chemistry. A, 124(20), 3984-3992 (2020-04-04)
D-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition.Cesira de Chiara et al.Nature chemical biology, 16(6), 686-694 (2020-03-24)
Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules.Sebastian Markmiller et al.Cell, 172(3), 590-604 (2018-01-27)
Switchable Synthesis of Pyrroles and Pyrazines via Rh(II)-Catalyzed Reaction of 1,2,3-Triazoles with Isoxazoles: Experimental and DFT Evidence for the 1,4-Diazahexatriene Intermediate.Nikolai V Rostovskii et al.The Journal of organic chemistry, 82(1), 256-268 (2016-12-16)
BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability.Laura E Jennings et al.Bioorganic & medicinal chemistry, 26(11), 2937-2957 (2018-05-20)
Deprotonation of Isoxazole: A Photoelectron Imaging Study.Adam A Wallace et al.The journal of physical chemistry. A, 124(38), 7768-7775 (2020-08-28)
Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology model.Afnan A Matti et al.Bioorganic & medicinal chemistry letters, 23(21), 5931-5935 (2013-09-18)
Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly.Sreejith J Nair et al.Nature structural & molecular biology, 26(3), 193-203 (2019-03-06)
Pro-apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro.Ilaria Lampronti et al.Oncology letters, 20(5), 151-151 (2020-09-17)
Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents.Marina N Semenova et al.ACS combinatorial science, 20(12), 700-721 (2018-11-20)
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases.Chao Li et al.Frontiers in pharmacology, 11, 1247-1247 (2020-09-29)
Isoxazoles: synthesis, evaluation and bioinformatic design as acetylcholinesterase inhibitors.Margarita Gutiérrez et al.The Journal of pharmacy and pharmacology, 65(12), 1796-1804 (2013-11-05)
Ultrafast photodegradation of isoxazole and isothiazolinones by UV254 and UV254/H2O2 photolysis in a microcapillary reactor.Danilo Russo et al.Water research, 169, 115203-115203 (2019-11-02)
Selective Mediator dependence of cell-type-specifying transcription.Martin G Jaeger et al.Nature genetics, 52(7), 719-727 (2020-06-03)
Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tethering.Scott Boitano et al.PloS one, 9(6), e99140-e99140 (2014-06-14)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!